Skip to main content
Clinical Trials/NCT05138640
NCT05138640
Completed
Not Applicable

Prospective Evaluation of Bone Strength, Physical Activity, Falls, Subsequent Fractures and Mortality in Patients Presenting With a Recent Clinical Fracture

Joop P.W. van den Bergh1 site in 1 country500 target enrollmentOctober 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fractures, Bone
Sponsor
Joop P.W. van den Bergh
Enrollment
500
Locations
1
Primary Endpoint
Bone strength assessed with HRpQCT
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The risk for a subsequent fracture is significantly higher in patients presenting with a fracture compared to individuals without a previous fracture and is highest within the first 2 years after the initial fracture. The risk for a subsequent fracture is not dependent of BMD as measured by conventional DXA. In recent studies, it has been shown that HRpQCT measurements provide information about bone structure, bone quality and bone strength in addition to BMD measurements. Diagnostic strategies should be focussed on bone quality and bone strength and fall prediction in the patients at high risk for falls, subsequent fracture and mortality such as patients with a recent fracture. Therefore, the investigators conduct a prospective observational study in 500 patients aged 50 years and older who present with a clinical fracture for evaluation of bone strength, physical activity, falls, subsequent fractures and mortality during a follow-up period of 3 years.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
July 2019
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Joop P.W. van den Bergh
Responsible Party
Sponsor Investigator
Principal Investigator

Joop P.W. van den Bergh

Clinical Professor

VieCuri Medical Centre

Eligibility Criteria

Inclusion Criteria

  • Patients aged 50 years and older with a recent fracture that is being evaluated at the FLS at VieCuri MC.
  • Patients who understand the conditions of the study and are willing and able to comply with the scheduled biochemical study procedures
  • Patients who signed the Ethics Committee approved specific Informed Consent Form prior to inclusion.

Exclusion Criteria

  • Patients with malignancy metastatic to the bone.
  • Patients with osteomyelitis.
  • Patients with fractures due to failure of a prosthesis.
  • Patients, who as judged by the Principal Investigator, are mentally incompetent. Patients who are compos mentis and understand the patient information, will not be considered mentally incompetent

Outcomes

Primary Outcomes

Bone strength assessed with HRpQCT

Time Frame: 3 years

Difference in bone strength, estimated by micro-finite element analyses, will be compared between patients with and without a subsequent fracture within 3 years of follow-up.

Secondary Outcomes

  • Subsequent falls within 3 years after a fracture(3 years)
  • Mortality(3 years)

Study Sites (1)

Loading locations...

Similar Trials